PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
K Priest Selected Research
SRL172
02/2005
Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control.
10/2000
A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
Articles by Research Topic
Disease
3
Mesothelioma
02/2006 - 10/2000
2
Small Cell Carcinoma
02/2005 - 10/2000
1
Weight Loss (Weight Reduction)
05/2004
1
Lung Neoplasms (Lung Cancer)
05/2004
Drug/Important Bio-Agent (IBA)
2
SRL172
IBA
02/2005 - 10/2000
1
Cisplatin (Platino)
FDA Link
Generic
09/2004
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
09/2004
1
Vinblastine (Vinblastine Sulfate)
FDA Link
09/2004
Therapy/Procedure
5
Drug Therapy (Chemotherapy)
02/2006 - 10/2000